Most studies on DNA-PKcs have focused on cancer [13]; however, an increasing body of evidence suggests that DNA-PKcs also contributes significantly to the progression of various diseases, including aging, pulmonary fibrosis, and hypoxic pulmonary arterial hypertension [8,12,14,15]. This evidence concerns the gene PRKDC and pulmonary fibrosis.